NYSEARCA:PSIL AdvisorShares Psychedelics ETF (PSIL) Price, Holdings, & News $11.99 -0.14 (-1.15%) (As of 11/4/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatings About AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PSIL alerts:Sign Up Key Stats Today's Range$11.95▼$12.0750-Day Range$0.80▼$15.6652-Week Range$7.14▼$17.00Volume2,882 shsAverage Volume11,908 shsMarket Capitalization$67.37 millionAssets Under Management$6.43 millionDividend Yield0.42%Net Expense Ratio0.99%Aggregate RatingModerate Buy ETF OverviewThe AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.Read More… Ticking time bomb. Detonation Nov 5 (Ad)Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late. Watch this video, it is being taken down Monday night AdvisorShares Psychedelics ETF ExpensesTypePSILTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.60%0.57%0.55%0.51%0.52%Other Expenses2.41%0.57%0.49%0.58%0.53%Total Expense3.01%0.72%0.71%0.73%0.71%Fee Waiver-2.02%-0.74%-0.52%-0.67%-0.57%Net Expense0.99%0.59%0.61%0.58%0.59% Receive PSIL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdvisorShares Psychedelics ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address PSIL ETF News HeadlinesDRUG Enhances Buzz for Psilocybin, Psychedelic ETFsOctober 18, 2024 | finance.yahoo.comAdvisorShares Psychedelics ETF (ARCA:PSIL), Short Interest ReportSeptember 12, 2024 | benzinga.comRigged election? Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late. November 4, 2024 | Porter & Company (Ad)AdvisorShares Announces Reverse Split of ETFAugust 30, 2024 | finance.yahoo.comAdvisorShares Psychedelics ETFFebruary 13, 2024 | thestreet.comPsyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And MoreDecember 18, 2023 | markets.businessinsider.comSee More Headlines PSIL ETF - Frequently Asked Questions How have PSIL shares performed this year? AdvisorShares Psychedelics ETF's stock was trading at $1.39 at the beginning of the year. Since then, PSIL stock has increased by 762.4% and is now trading at $11.9869. View the best growth stocks for 2024 here. How do I buy shares of AdvisorShares Psychedelics ETF? Shares of PSIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of AdvisorShares Psychedelics ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that AdvisorShares Psychedelics ETF investors own include Tilray (TLRY), Bright Minds Biosciences (DRUG), Las Vegas Sands (LVS), NVIDIA (NVDA), Archer Aviation (ACHR), Blade Air Mobility (BLDE) and Blink Charging (BLNK). Fund Details IssuerAdvisorShares Fund NameAdvisorShares Psychedelics ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PSIL Inception Date9/15/2021 Fund ManagerDan S. Ahrens WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings28 Fund Statistics Assets Under Management$6.43 million Average Daily Volume$0.00 Discount/Premium0.12% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorAdvisorShares Investments, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume11 Put Options14 Call Options11 Short Interest11,900 shs Miscellaneous Outstanding Shares5,620,000Beta0.87 Creation Fee$500.00 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report Top 10 PSIL HoldingsMind Medicine (MindMed) (NASDAQ:MNMD)Holding Weight: 13.78%Cybin Inc.Holding Weight: 9.62%Bright Minds Biosciences Inc.Holding Weight: 9.00%COMPASS Pathways (NASDAQ:CMPS)Holding Weight: 5.83%Alkermes (NASDAQ:ALKS)Holding Weight: 5.23%Clearmind Medicine (NASDAQ:CMND)Holding Weight: 5.23%Relmada Therapeutics (NASDAQ:RLMD)Holding Weight: 4.99%GH Research (NASDAQ:GHRS)Holding Weight: 4.91%Atai Life Sciences (NASDAQ:ATAI)Holding Weight: 4.80%Intra-Cellular Therapies (NASDAQ:ITCI)Holding Weight: 4.50%Full Holdings DetailsPSIL Sector ExposurePSIL Industry Exposure This page (NYSEARCA:PSIL) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PSIL Stock Alerts